OPRA Medicinal Chemistry 2027: Syllabus & MCQs
Medicinal Chemistry and Biopharmaceutics accounts for approximately 10% of the OPRA exam syllabus, making it an important subject for overseas-qualified pharmacists preparing for the Australian Pharmacy Council (APC) examination.
For candidates preparing for the OPRA exam in 2027, this subject requires an understanding of drug properties, pharmaceutical formulations, solubility, chemical stability and drug delivery systems.
Many pharmacy graduates concentrate on pharmacology and therapeutics while overlooking the scientific principles behind how medicines are formulated and delivered.
However, understanding how a drug's chemical properties influence its formulation, dissolution and stability is an important part of pharmaceutical science.
This guide explains the OPRA Medicinal Chemistry and Biopharmaceutics syllabus for 2027, including important topics, preparation strategies, original practice MCQs and frequently asked questions.
What Is Medicinal Chemistry and Biopharmaceutics in the OPRA Exam?
Medicinal Chemistry and Biopharmaceutics is one of the five content areas assessed in the Overseas Pharmacist Readiness Assessment.
This subject focuses on the chemical and physicochemical properties of drugs and the principles involved in developing stable, effective pharmaceutical formulations.
Medicinal chemistry examines the relationship between molecular structure, chemical properties and biological behaviour.
Biopharmaceutics explores how pharmaceutical formulations and drug properties influence drug availability and absorption.
According to the APC examination guide, the content area contains six major sections:
Physicochemical properties of drugs
Formulations for drug delivery
Drug and chemical stability
Drug solubility and dissolution
Pharmaceutical formulation methods
Pharmaceutical microbiology
Understanding these topics can help candidates connect fundamental pharmaceutical chemistry with practical formulation principles.
OPRA Medicinal Chemistry and Biopharmaceutics Weightage
The OPRA examination consists of 120 multiple-choice questions completed within 150 minutes.
The APC examination blueprint allocates questions across five content areas.
| OPRA syllabus subject | Approximate weightage |
|---|---|
| Therapeutics and Patient Care | 45% |
| Biomedical Sciences | 20% |
| Pharmacology and Toxicology | 15% |
| Pharmacokinetics and Pharmacodynamics | 10% |
| Medicinal Chemistry and Biopharmaceutics | 10% |
| Total | 100% |
Although this subject accounts for approximately 10% of the examination blueprint, candidates should not assume they will receive exactly 12 scored questions from this area.
The examination includes scored and unscored questions, and the published percentages reflect the assessment blueprint.
There is no separate passing score for Medicinal Chemistry and Biopharmaceutics. APC determines examination success based on overall performance.
For the complete subject breakdown, read our OPRA Exam Syllabus Guide.
Important Topics in OPRA Medicinal Chemistry and Biopharmaceutics
The following table summarises the six syllabus sections published by APC.
| Syllabus section | Important concepts |
|---|---|
| Physicochemical properties | Ionisation, lipophilicity, partitioning and properties affecting ADME |
| Drug delivery formulations | Solids, solutions, suspensions, emulsions and dosage forms |
| Drug stability | Hydrolysis, oxidation, zero-order and first-order degradation |
| Solubility | Dissolution, partitioning and factors affecting solubility |
| Drug formulation | Oral, pulmonary, transdermal, parenteral and other delivery routes |
| Pharmaceutical microbiology | Preservation, antimicrobial agents and sterilisation |
These areas provide a structured framework for OPRA preparation.
1. Physicochemical Properties of Drugs
Physicochemical properties influence how drugs behave within pharmaceutical formulations and biological environments.
Important concepts include molecular size, ionisation, solubility, lipophilicity and chemical structure.
Ionisation and pKa
The ionisation of a drug depends on its chemical properties and the pH of the surrounding environment.
Weak acidic and weak basic drugs can exist in ionised and unionised forms.
For a typical weak acid, increasing the pH above its pKa increases the proportion present in the ionised form.
For a typical weak base, lowering the pH below its pKa increases the proportion present in the protonated form.
These relationships influence solubility, partitioning and membrane transport.
Lipophilicity
Lipophilicity describes a substance's tendency to associate with lipid environments.
It can affect membrane permeability, distribution and formulation behaviour.
However, greater lipophilicity does not always mean better oral absorption because aqueous solubility and other factors are also important.
Partition coefficient
The partition coefficient describes the distribution of a substance between two immiscible phases.
It helps explain how chemical properties influence partitioning and potential membrane interactions.
Candidates should understand these concepts rather than relying only on memorised definitions.
2. Pharmaceutical Dosage Forms
The OPRA syllabus includes properties of solids, liquid formulations, solutions, suspensions and emulsions.
Different dosage forms are designed to meet specific drug-delivery requirements.
| Dosage form | Main characteristic |
|---|---|
| Tablet | Solid dosage form containing drug and suitable excipients |
| Capsule | Drug contained within a shell |
| Solution | Drug or solute dissolved in a suitable solvent |
| Suspension | Insoluble solid particles dispersed in a liquid medium |
| Emulsion | One liquid dispersed as droplets within another immiscible liquid |
| Ointment | Semisolid preparation for topical application |
| Transdermal patch | Designed to deliver suitable drugs across the skin |
Solutions vs suspensions
In a solution, the solute is dissolved at the molecular or ionic level.
In a suspension, undissolved particles are dispersed throughout a liquid.
Suspensions may require shaking before administration to redistribute settled particles.
Emulsions
An emulsion contains droplets of one liquid dispersed in another liquid.
Emulsifying agents can help stabilise these systems by reducing interfacial tension and creating barriers against droplet coalescence.
Candidates should understand the scientific principles behind each formulation.
3. Drug Stability and Degradation
Drug stability is an important topic within the Medicinal Chemistry and Biopharmaceutics syllabus.
Pharmaceutical products can undergo chemical or physical changes during manufacturing, storage and use.
Two important chemical degradation mechanisms are hydrolysis and oxidation.
Hydrolysis
Hydrolysis involves chemical bond cleavage through reaction with water.
Certain chemical groups, including many esters, can be susceptible to hydrolytic degradation.
Factors such as moisture, temperature and pH may influence the rate of hydrolysis.
Oxidation
Oxidation involves chemical reactions associated with electron transfer and changes in oxidation state.
Some medicines are susceptible to oxidation during storage.
Formulation strategies may include appropriate packaging, antioxidants or controlling exposure to oxygen, where suitable for the product.
Zero-order and first-order degradation
| Property | Zero-order degradation | First-order degradation |
|---|---|---|
| Rate dependence | Constant amount degrades per unit time | Constant fraction degrades per unit time |
| Concentration relationship | Linear decrease with time | Exponential decrease with time |
| Rate constant units | Concentration/time | Reciprocal time |
| Typical equation | C = C₀ − kt | C = C₀e⁻ᵏᵗ |
In ideal first-order degradation, the half-life is:
t½ = 0.693/k
Candidates should understand the difference between these kinetic models and how degradation affects product stability.
The principles of pharmaceutical stability testing are also addressed in the ICH Q1A(R2) guideline adopted by Australia's Therapeutic Goods Administration (TGA).
4. Drug Solubility and Dissolution
Solubility and dissolution are related but distinct pharmaceutical concepts.
Solubility refers to the maximum equilibrium amount of a substance that can dissolve in a particular solvent under specified conditions.
Dissolution describes the process and rate at which a substance enters solution.
Factors influencing solubility and dissolution include:
Temperature
pH and ionisation
Solvent properties
Solid-state form
Particle size and exposed surface area
Agitation and dissolution conditions
Reducing particle size can increase the surface area available for dissolution and often improves dissolution rate.
However, reducing particle size does not necessarily increase equilibrium solubility.
These differences are important when evaluating formulation strategies.
5. Drug Delivery Systems
The OPRA examination also assesses formulation principles for several administration routes.
Oral formulations
These include tablets, capsules, solutions and suspensions.
Formulations may be designed for immediate, delayed or modified release.
Pulmonary delivery
Inhalation formulations deliver medicines through the respiratory system.
Particle characteristics and device performance influence deposition.
Transdermal delivery
Transdermal systems are designed to deliver suitable molecules across the skin.
Drug properties and formulation design influence permeability.
Parenteral delivery
Parenteral preparations bypass the gastrointestinal tract and include injectable medicines.
Sterility, compatibility and appropriate pharmaceutical quality are critical considerations.
Ophthalmic delivery
Ophthalmic medicines must meet relevant requirements for administration to the eye, including sterility for ophthalmic preparations.
Candidates should understand how the administration route influences formulation design and quality requirements.
6. Pharmaceutical Microbiology
Pharmaceutical microbiology addresses the prevention and control of microbial contamination in medicines.
The official OPRA syllabus includes preservation, antimicrobial agents and sterilisation.
Preservation
Antimicrobial preservatives may be added to certain formulations to control microbial growth during appropriate storage and use.
However, preservatives are not substitutes for adequate manufacturing controls or required sterilisation.
Sterilisation
Sterilisation processes aim to achieve the required assurance of freedom from viable microorganisms.
Different methods include moist heat, dry heat, filtration and radiation, depending on the product and process.
Microbial contamination
Contamination can compromise pharmaceutical quality and potentially harm patients.
Candidates should understand the differences between preservation, disinfection, sterilisation and aseptic processing.
OPRA Medicinal Chemistry and Biopharmaceutics Practice MCQs
The following questions are original educational examples created for OPRA preparation. They are not official or recalled APC examination questions.
Question 1: Drug Ionisation
A weak acidic drug is placed in a solution with a pH substantially above its pKa.
Which change is MOST likely?
A. A greater proportion exists in the ionised form
B. The drug becomes completely unionised
C. The drug undergoes immediate oxidation
D. The molecular weight increases
Correct Answer: A. A greater proportion exists in the ionised form
Explanation: Weak acids become increasingly deprotonated as pH rises above their pKa. The deprotonated form is generally ionised.
Question 2: Chemical Stability
Which chemical functional group is commonly susceptible to hydrolysis?
A. Saturated hydrocarbon
B. Ester
C. Alkane carbon-carbon bond
D. Aromatic carbon-carbon bond
Correct Answer: B. Ester
Explanation: Ester bonds can undergo hydrolytic cleavage under suitable conditions. The rate depends on the molecular structure and environmental factors.
Question 3: First-Order Degradation
Which statement BEST describes an ideal first-order degradation process?
A. The same absolute amount degrades every hour
B. The reaction rate is independent of concentration
C. A constant fraction degrades per unit time
D. Degradation cannot occur in aqueous solutions
Correct Answer: C. A constant fraction degrades per unit time
Explanation: In first-order kinetics, the degradation rate is proportional to the remaining concentration.
Question 4: Pharmaceutical Suspensions
Which statement BEST describes a pharmaceutical suspension?
A. It contains only dissolved molecules
B. It always consists of two immiscible liquids
C. It contains only gaseous components
D. It contains solid particles dispersed in a liquid medium
Correct Answer: D. It contains solid particles dispersed in a liquid medium
Explanation: Suspensions contain undissolved solid particles distributed throughout a liquid. Physical stability and redispersibility are important formulation considerations.
Question 5: Emulsions
What is the primary role of an emulsifying agent in an emulsion?
A. To convert all ingredients into gases
B. To help stabilise dispersed droplets and reduce interfacial tension
C. To eliminate every microorganism
D. To guarantee complete drug absorption
Correct Answer: B. To help stabilise dispersed droplets and reduce interfacial tension
Explanation: Emulsifiers help maintain the dispersion of immiscible liquid phases by acting at their interface.
Question 6: Dissolution
A poorly water-soluble drug is micronised, increasing its available surface area.
Which outcome is MOST likely under otherwise comparable dissolution conditions?
A. The equilibrium solubility always doubles
B. The drug immediately becomes chemically unstable
C. The dissolution rate may increase
D. The drug's molecular structure necessarily changes
Correct Answer: C. The dissolution rate may increase
Explanation: Increased exposed surface area commonly improves the dissolution rate. This does not necessarily change equilibrium solubility.
Question 7: Pharmaceutical Microbiology
Which statement about antimicrobial preservatives is CORRECT?
A. They do not replace required sterilisation and manufacturing controls
B. They guarantee complete sterility in all formulations
C. They eliminate the need for product stability testing
D. They make every non-sterile medicine suitable for injection
Correct Answer: A. They do not replace required sterilisation and manufacturing controls
Explanation: Preservatives may help control microbial growth in suitable products, but they cannot substitute for required sterility assurance or appropriate manufacturing practices.
Question 8: Parenteral Formulations
Which quality requirement is essential for injectable pharmaceutical preparations?
A. Every formulation must be an emulsion
B. Every formulation must contain ethanol
C. Every formulation must be administered orally first
D. The preparation must meet applicable sterility requirements
Correct Answer: D. The preparation must meet applicable sterility requirements
Explanation: Injectable pharmaceutical products must meet stringent quality and sterility requirements because they bypass important protective barriers.
How to Prepare for OPRA Medicinal Chemistry and Biopharmaceutics
A structured revision strategy can help candidates strengthen their understanding of this subject.
Begin with physicochemical properties, including ionisation, lipophilicity and partitioning.
Next, compare common dosage forms and learn how formulation design affects drug delivery.
Dedicate separate revision sessions to chemical stability, hydrolysis, oxidation, solubility and dissolution.
Finally, review pharmaceutical microbiology, including preservatives and sterilisation processes.
Use comparison tables and practice MCQs to identify concepts that require additional revision.
Seven-Day Revision Timetable
| Day | Study focus |
|---|---|
| Day 1 | Physicochemical properties, ionisation and pKa |
| Day 2 | Solutions, suspensions, emulsions and solid dosage forms |
| Day 3 | Drug stability, hydrolysis and oxidation |
| Day 4 | Zero-order and first-order degradation |
| Day 5 | Solubility, dissolution and partitioning |
| Day 6 | Drug delivery systems and pharmaceutical microbiology |
| Day 7 | Mixed MCQs, weak-area revision and error analysis |
This is an independent study suggestion, not an APC-prescribed timetable.
Common Mistakes to Avoid
Confusing solubility with dissolution: Equilibrium solubility and dissolution rate measure different properties.
Ignoring pH and ionisation: Drug charge and environmental pH can influence formulation and biological behaviour.
Memorising formulations without understanding their properties: Learn why different dosage forms are selected.
Treating preservatives as equivalent to sterilisation: Preservatives do not guarantee sterility.
Neglecting lower-weighted syllabus areas: Although this subject has a 10% allocation, all five OPRA content areas contribute to the overall assessment.
Conclusion
Preparing for OPRA Medicinal Chemistry and Biopharmaceutics in 2027 requires a clear understanding of how drug properties influence formulation, stability, dissolution and drug delivery.
Although this subject accounts for approximately 10% of the examination blueprint, it forms an important part of the pharmaceutical science knowledge assessed in OPRA.
Focus on understanding the scientific principles behind physicochemical properties, pharmaceutical formulations, chemical degradation and pharmaceutical microbiology.
Use suitable reference materials, practise independently developed MCQs and integrate this subject into your broader OPRA preparation timetable.
Explore Free OPRA Preparation Resources
Need help organising your OPRA studies? Request free OPRA preparation guidance through the enquiry form on OPRAExam.in.
The website provides independent educational guidance and is not affiliated with the APC examination registration process.
Official References
Australian Pharmacy Council — OPRA Exam Guide and Sample Content
Therapeutic Goods Administration — ICH Q1A(R2) Stability Testing
Last reviewed: 5 November 2026
Disclaimer: OPRAExam.in is an independent educational website and is not affiliated with or endorsed by the Australian Pharmacy Council. All practice questions are original educational examples. The subject outline is based on APC's guide published in July 2026; candidates should check for subsequent updates before their 2027 examination.
Frequently Asked Questions
Common questions about OPRA Medicinal Chemistry 2027: Syllabus & MCQs.
What is the weightage of Medicinal Chemistry and Biopharmaceutics in OPRA?
The Australian Pharmacy Council allocates approximately 10% of the OPRA examination blueprint to Medicinal Chemistry and Biopharmaceutics.
What topics are included in OPRA Medicinal Chemistry?
Important topics include physicochemical drug properties, formulation principles, chemical stability, solubility, dissolution, drug delivery systems and pharmaceutical microbiology.
Are hydrolysis and oxidation included in the OPRA exam?
Yes. The official syllabus lists hydrolysis and oxidation as examples of drug degradation mechanisms.
Is pharmaceutical microbiology included?
Yes. The syllabus includes preservation, antimicrobial agents and sterilisation processes.
Are pharmaceutical formulations important for OPRA?
Yes. Candidates should understand solid and liquid dosage forms and the principles of drug delivery through different administration routes.
Is there a separate passing score for Medicinal Chemistry?
No. APC determines OPRA examination outcomes according to overall performance rather than individual subject passing scores.
How should I prepare for OPRA Biopharmaceutics?
Start with the official syllabus, understand important scientific concepts, compare dosage forms, practise application-based questions and regularly review mistakes.